A Dallas jury found transvaginal mesh manufacturer Ethicon and its parent company Johnson & Johnson liable for defects associated with the company’s TVT-O transvaginal mesh sling. The mesh patient, Linda Batiste, was awarded $1.2 million for suffering serious health issues from her transvaginal mesh implant. The trial lasted more than two weeks, and is another notable verdict in the transvaginal mesh litigation. The transvaginal mesh lawyers at Baron and Budd support the verdict and wish to congratulate the trial team on a job well done.

“This is an excellent result for all women who have been harmed by transvaginal mesh implants,” said Stephen Blackburn, attorney at Baron and Budd. “This case will help to set a precedent for future transvaginal mesh sling cases, and we couldn’t be happier that the verdict came back in favor of the patient.” Sadly, like Ms. Batiste, many patients have been forced to undergo a second surgery to correct issues with TVT slings after they are implanted. The mechanically cut TVT-O mesh is still being used today alongside other products like the TVT-Secur and TVT-Abrevo.

Baron and Budd has been protecting the rights of consumers for more than 35 years. The firm is at the forefront of meaningful litigation and has been active in the area of dangerous pharmaceutical products for decades. Firm co-founder and shareholder Russell Budd currently serves on the Transvaginal Mesh Plaintiffs’ Steering Committee. Baron and Budd shareholders also currently serve on Plaintiffs’ Steering Committee in the GranuFlo/NaturaLyte litigation. The firm has represented thousands of people harmed by the diabetes drug Avandia, as well as numerous states in lawsuits regarding the deceptive marketing of Avandia. Previously, the firm helped negotiate a $1.275 billion settlement for people who had been harmed by the diet drug Fen-Phen.